Knee Osteoarthritis Clinical Trials 2024

Knee Osteoarthritis Clinical Trials 2024

Knee Osteoarthritis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in knee osteoarthritis clinical trials today.

Knee Osteoarthritis Clinical Trials

Here are the 6 most popular medical studies for knee osteoarthritis

Popular filter options for knee osteoarthritis trials

OA Clinical Trials

View 70 OA medical studies.

Osteoarthritis Clinical Trials

View 69 Osteoarthritis medical studies.

Phase 3 Knee Osteoarthritis Clinical Trials

View 76 phase 3 knee osteoarthritis medical studies.

Knee Osteoarthritis Clinical Trials With No Placebo

View 76 knee osteoarthritis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to knee osteoarthritis

What are the top hospitals conducting knee osteoarthritis research?

When it comes to advancing research and finding innovative treatments for knee osteoarthritis, several hospitals are making significant contributions. In Seattle, the University of Washington is at the forefront with three ongoing clinical trials dedicated to this condition. While they may not have conducted any previous knee osteoarthritis trials, their active involvement demonstrates a commitment to improving patient outcomes. Similarly, in Salt Lake City, the University of Utah is also conducting three active knee osteoarthritis trials, signaling their dedication to exploring new treatment options. Moving towards BioSolutions Clinical Research Center in La Mesa and Affinity Health in Oak Brook both hosting two ongoing investigations related to this condition; each institution aims at creating breakthroughs that can make a substantial impact on patients' lives. Lastly joining them is Healthcare Research Network located in Hazelwood where multiple efforts are underway to understand and develop innovative approaches against knee osteoarthritis.

Knee osteoarthritis affects millions of people worldwide and can cause pain, stiffness, and reduced mobility. By actively engaging in these clinical trials for knee osteoarthritis across various locations throughout the United States healthcare landscape offers hope for those suffering from this degenerative joint disease.

Which are the best cities for knee osteoarthritis clinical trials?

In the realm of knee osteoarthritis clinical trials, several cities emerge as prominent hubs for research. La Mesa, California leads the way with 8 active trials investigating treatments like Lorecivivint, canakinumab, and JointStem. San Antonio, Texas also boasts 8 ongoing studies focusing on interventions such as Lorecivivint, DoD/VA CPG Core Set + PT, and Microfragmented Adipose Tissue (Mfat). Chicago, Illinois follows closely behind with 7 active trials delving into potential treatments like Lorecivivint, DFV890, and Naproxen 500 Mg. Together these cities provide individuals suffering from knee osteoarthritis access to cutting-edge clinical trials that pave the path towards advancements in treatment options and improved quality of life.

Which are the top treatments for knee osteoarthritis being explored in clinical trials?

Clinical trials are at the forefront of advancing treatment options for knee osteoarthritis. Among the top treatments being explored in these trials are:

  • Platelet-rich plasma (PRP): A therapy that utilizes a concentrated dose of platelets from the patient's own blood to stimulate healing and reduce inflammation.
  • Mesenchymal stem cells (MSCs): Stem cell-based therapies that have shown promise in promoting tissue regeneration and reducing pain.
  • Hyaluronic acid injections: Injections of hyaluronic acid into the affected joint, providing lubrication and cushioning to alleviate symptoms. These treatments offer hope for patients with knee osteoarthritis, potentially improving their quality of life by addressing pain and mobility issues.
What are the most recent clinical trials for knee osteoarthritis?

Recent clinical trials offer hope for individuals suffering from knee osteoarthritis. Group A TA 40 mg, a Phase 4 trial, has shown promise in providing relief for those with this degenerative joint disease. Additionally, GNSC-001 (low dose), Kenalog with 0ml bupivacaine, RHH646, and Microfragmented Adipose Tissue (Mfat) have also demonstrated potential benefits as treatment options for knee osteoarthritis during their respective phases of research. These studies mark significant strides in the quest to improve the quality of life for patients grappling with this debilitating condition.

What knee osteoarthritis clinical trials were recently completed?

Several recent clinical trials have focused on advancing our understanding and treatment of knee osteoarthritis. Notably, a trial sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) investigating the efficacy of Lasmiditan in managing this condition was recently completed. Additionally, another significant study led by the Hospital for Special Surgery examined the potential benefits of Platelet-Rich Plasma (PRP) injections for knee osteoarthritis patients. These advancements provide valuable insights into new therapeutic approaches that may help alleviate symptoms and improve quality of life for individuals living with knee osteoarthritis.